SC

SCM Lifescience Co., Ltd.

Develops high-purity stem cell therapeutics for difficult-to-treat diseases.

298060 | KO

Overview

Corporate Details

ISIN(s):
KR7298060005
LEI:
Country:
South Korea
Address:
인천광역시 연수구 갯벌로145번길 7-7 (송도동, 에스씨엠생명과학(주)), 인천광역시

Description

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
주요사항보고서(회사합병결정)
Korean 93.1 KB
2025-09-17 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.7 KB
2025-09-15 00:00
증권발행결과(자율공시) (제1회차 CB)
Korean 6.2 KB
2025-09-15 00:00
합병등종료보고서(자산양수도)
Korean 15.4 KB
2025-09-08 00:00
주요사항보고서(유상증자결정)
Korean 47.9 KB
2025-09-08 00:00
주요사항보고서(전환사채권발행결정)
Korean 59.2 KB
2025-09-05 00:00
주요사항보고서(타법인주식및출자증권양수결정)
Korean 34.0 KB
2025-09-05 00:00
주요사항보고서(전환사채권발행결정)
Korean 51.5 KB
2025-09-02 00:00
[기재정정]주식등의대량보유상황보고서(일반)
Korean 147.7 KB
2025-09-02 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 52.5 KB
2025-09-01 00:00
주식등의대량보유상황보고서(일반)
Korean 85.3 KB
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
타인에대한담보제공결정
Korean 20.2 KB
2025-08-08 00:00
타인에대한담보제공결정
Korean 19.4 KB

Automate Your Workflow. Get a real-time feed of all SCM Lifescience Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SCM Lifescience Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SCM Lifescience Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.